Related references
Note: Only part of the references are listed.Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progression
Antonio G. Solimando et al.
HAEMATOLOGICA (2021)
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism
Faroogh Marofi et al.
STEM CELL RESEARCH & THERAPY (2021)
Dynamic CD138 surface expression regulates switch between myeloma growth and dissemination
Ilseyar Akhmetzyanova et al.
LEUKEMIA (2020)
Cancer Cell Dormancy in Metastasis
Matthew A. Summers et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)
VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo
Tengteng Yu et al.
BLOOD CANCER JOURNAL (2020)
Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma
A. Lagana et al.
LEUKEMIA (2018)
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma
A. G. Solimando et al.
LEUKEMIA (2018)
Junctional adhesion molecule C (JAM-C) dimerization aids cancer cell migration and metastasis
Sarah Garrido-Urbani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)
Endosteal and Perivascular Subniches in a 3D Bone Marrow Model for Multiple Myeloma
Maaike V. J. Braham et al.
TISSUE ENGINEERING PART C-METHODS (2018)
Global Burden of Multiple Myeloma ASystematic Analysis for the Global Burden of Disease Study 2016
Andrew J. Cowan et al.
JAMA ONCOLOGY (2018)
JUNCTIONAL ADHESION MOLECULES (JAMs): CELL ADHESION RECEPTORS WITH PLEIOTROPIC FUNCTIONS IN CELL PHYSIOLOGY AND DEVELOPMENT
Klaus Ebnet
PHYSIOLOGICAL REVIEWS (2017)
Thrombopoiesis is spatially regulated by the bone marrow vasculature
David Stegner et al.
NATURE COMMUNICATIONS (2017)
Current applications of multiparameter flow cytometry in plasma cell disorders
T. Jelinek et al.
BLOOD CANCER JOURNAL (2017)
Multiple myeloma in the marrow: pathogenesis and treatments
Heather Fairfield et al.
MARROW (2016)
A CD138-independent strategy to detect minimal residual disease and circulating tumour cells in multiple myeloma
Barbara Muz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Anti-JAM-C therapy eliminates tumor engraftment in a xenograft model of mantle cell lymphoma
Carmen Donate et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Microenvironment drug resistance in multiple myeloma: emerging new players
Lucia Di Marzo et al.
ONCOTARGET (2016)
How leukocytes cross the vascular endothelium
Dietmar Vestweber
NATURE REVIEWS IMMUNOLOGY (2015)
Robust isolation of malignant plasma cells in multiple myeloma
Ildiko Frigyesi et al.
BLOOD (2014)
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
S. K. Kumar et al.
LEUKEMIA (2014)
A novel llama antibody targeting Fn14 exhibits anti-metastatic activity in vivo
Johannes Trebing et al.
MABS (2014)
Endothelial cell junctional adhesion molecule C plays a key role in the development of tumors in a murine model of ovarian cancer
David A. Leinster et al.
FASEB JOURNAL (2013)
The Junctional Adhesion Molecule-B regulates JAM-C-dependent melanoma cell metastasis
Marie-Laure Arcangeli et al.
FEBS LETTERS (2012)
Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide
Yawara Kawano et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Mapping immune processes in intact tissues at cellular resolution
Christian Brede et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Non-Invasive Imaging Provides Spatiotemporal Information on Disease Progression and Response to Therapy in a Murine Model of Multiple Myeloma
Simone S. Riedel et al.
PLOS ONE (2012)
Targeting the Tumor Microenvironment: Focus on Angiogenesis
Fengjuan Fan et al.
JOURNAL OF ONCOLOGY (2012)
The bone marrow at the crossroads of blood and immunity
Francois E. Mercier et al.
NATURE REVIEWS IMMUNOLOGY (2012)
The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications
Klaus Podar et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
A Novel Function of Junctional Adhesion Molecule-C in Mediating Melanoma Cell Metastasis
Harald F. Langer et al.
CANCER RESEARCH (2011)
Junctional adhesion molecules are required for melanoma cell lines transendothelial migration in vitro
Stephanie Ghislin et al.
PIGMENT CELL & MELANOMA RESEARCH (2011)
Cell surface proteomics identifies molecules functionally linked to tumor cell intravasation
Erin M. Conn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Junctional adhesion molecule-C promotes metastatic potential of HT1080 human fibrosarcoma
Chiaki Fuse et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The role of junctional adhesion molecules in vascular inflammation
Christian Weber et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Metastasis: a question of life or death
P Mehlen et al.
NATURE REVIEWS CANCER (2006)
The homophilic binding of junctional adhesion molecule-C mediates tumor cell-endothelial cell interactions
S Santoso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Antibody against junctional adhesion molecule-C inhibits angiogenesis and tumor growth
C Lamagna et al.
CANCER RESEARCH (2005)
Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration
CA Johnson-Léger et al.
BLOOD (2002)
Share Paper
